
LINK . SPRINGER . COM {
}
Title:
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma | Cancer Immunology, Immunotherapy
Description:
Radio-labelling of blood cells is an established technique for evaluating in vivo migration of normal cells to sites of pathology such as infection and haemorrhage. A limitation of cellular immunotherapies to induce anti-tumour responses is in part due to the uncertain ability of cellular effectors to reach their intended target. We extended the approach of cell radiolabelling to accurately examine the in vivo distribution of cellular immunotherapy with ex-vivo macrophage activated killer (MAK) cells. We describe the use of two methods of cell labelling for tracking the destination of autologous-derived macrophage activated killer (MAK®) cells linked to the bi-specific antibody MDX-H210 delivered either by intravenous (i.v.) or intraperitoneal (i.p.) injection in ten patients with peritoneal relapse of epithelial ovarian carcinoma. Our results demonstrate the feasibility of generating high numbers and purity of GMP quality MAK cells, which can be radiolabelled with 18F-FDG or 111In-oxime. MAK cell administration produced minimal infusional toxicity and demonstrated a reproducible pattern of in vivo distribution and active in vivo tracking to sites of known tumour following 8 of 16 i.v. infusions or 4 of 6 i.p. infusions. However, the leakage of 18F-FDG limited the ability to confidently confirm the tracking of MAK cells to tumour in all cases and improved PET labels are required. The addition of MDX-H210 bispecific antibody did not alter the distribution of cells to tumour sites, but did accelerate the clearance of i.v. administered MAK cells from the pulmonary circulation. This data demonstrates that cellular cancer immunotherapies may be successfully delivered to the sites of active tumour following either i.v. or i.p. injection in a proportion of patients with metastatic cancer. Incorporation of tracking studies in early cycles of cellular immunotherapy may allow selection of patients who demonstrate successful targeting of the immunotherapy for ongoing treatment.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Telecommunications
- Science
- Health & Fitness
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We see no obvious way the site makes money.
While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.
Keywords {🔍}
article, google, scholar, cancer, pubmed, cas, cells, immunotherapy, macrophages, cellular, bartholeyns, vivo, cell, patients, tracking, activated, ovarian, mak, access, sites, carcinoma, monocytes, oncol, immunol, privacy, cookies, content, macrophage, prince, chokri, human, poindron, immunother, data, publish, research, search, killer, ritchie, mileshkin, wall, distribution, tumour, open, clin, clinical, adoptive, melbourne, information, log,
Topics {✒️}
month download article/chapter bispecific antibody mdx-h210 mdx-h210 bispecific antibody imaging cell trafficking human-activated macrophages produced large scale isolation induce anti-tumour responses stem cells article cancer immunology administered mak cells vivo cell labeling full article pdf privacy choices/manage cookies improved pet labels related subjects human macrophages produced activated macrophages proliferating activated macrophages grown metastatic ovarian carcinoma cellular cancer immunotherapies cell labelling epithelial ovarian carcinoma counterflow centrifugation elutriation car macrophages directs indium-labelled macrophages scope submit manuscript generating high numbers multi-dimensional characterization cytokine secretion profile human monocytes cultured anti-tumor properties de gramont topoisomerase ii-alpha romet-lemonne jl infarcted human myocardium 64cu-pyruvaldehyde-bis positron-emission tomography 6th framework programme diagnostic imaging conditions privacy policy potent antitumoral properties adoptive cellular immunotherapy cell radiolabelling european economic area demonstrate successful targeting human blood monocytes 18f-fdg limited 18f-fdg labelling cd64-directed immunotherapy compared antitumoral effects
Schema {🗺️}
WebPage:
mainEntity:
headline:In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma
description:Radio-labelling of blood cells is an established technique for evaluating in vivo migration of normal cells to sites of pathology such as infection and haemorrhage. A limitation of cellular immunotherapies to induce anti-tumour responses is in part due to the uncertain ability of cellular effectors to reach their intended target. We extended the approach of cell radiolabelling to accurately examine the in vivo distribution of cellular immunotherapy with ex-vivo macrophage activated killer (MAK) cells. We describe the use of two methods of cell labelling for tracking the destination of autologous-derived macrophage activated killer (MAK®) cells linked to the bi-specific antibody MDX-H210 delivered either by intravenous (i.v.) or intraperitoneal (i.p.) injection in ten patients with peritoneal relapse of epithelial ovarian carcinoma. Our results demonstrate the feasibility of generating high numbers and purity of GMP quality MAK cells, which can be radiolabelled with 18F-FDG or 111In-oxime. MAK cell administration produced minimal infusional toxicity and demonstrated a reproducible pattern of in vivo distribution and active in vivo tracking to sites of known tumour following 8 of 16 i.v. infusions or 4 of 6 i.p. infusions. However, the leakage of 18F-FDG limited the ability to confidently confirm the tracking of MAK cells to tumour in all cases and improved PET labels are required. The addition of MDX-H210 bispecific antibody did not alter the distribution of cells to tumour sites, but did accelerate the clearance of i.v. administered MAK cells from the pulmonary circulation. This data demonstrates that cellular cancer immunotherapies may be successfully delivered to the sites of active tumour following either i.v. or i.p. injection in a proportion of patients with metastatic cancer. Incorporation of tracking studies in early cycles of cellular immunotherapy may allow selection of patients who demonstrate successful targeting of the immunotherapy for ongoing treatment.
datePublished:2006-05-30T00:00:00Z
dateModified:2006-05-30T00:00:00Z
pageStart:155
pageEnd:163
sameAs:https://doi.org/10.1007/s00262-006-0181-3
keywords:
Immunotherapy
Macrophage
Radiolabel
PET
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig4_HTML.jpg
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:56
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:D. Ritchie
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:L. Mileshkin
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:D. Wall
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:J. Bartholeyns
affiliation:
name:Immuno-Designed Molecules
address:
name:Immuno-Designed Molecules, Paris, France
type:PostalAddress
type:Organization
type:Person
name:M. Thompson
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:J. Coverdale
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:E. Lau
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:J. Wong
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:P. Eu
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:R. J. Hicks
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:H. M. Prince
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma
description:Radio-labelling of blood cells is an established technique for evaluating in vivo migration of normal cells to sites of pathology such as infection and haemorrhage. A limitation of cellular immunotherapies to induce anti-tumour responses is in part due to the uncertain ability of cellular effectors to reach their intended target. We extended the approach of cell radiolabelling to accurately examine the in vivo distribution of cellular immunotherapy with ex-vivo macrophage activated killer (MAK) cells. We describe the use of two methods of cell labelling for tracking the destination of autologous-derived macrophage activated killer (MAK®) cells linked to the bi-specific antibody MDX-H210 delivered either by intravenous (i.v.) or intraperitoneal (i.p.) injection in ten patients with peritoneal relapse of epithelial ovarian carcinoma. Our results demonstrate the feasibility of generating high numbers and purity of GMP quality MAK cells, which can be radiolabelled with 18F-FDG or 111In-oxime. MAK cell administration produced minimal infusional toxicity and demonstrated a reproducible pattern of in vivo distribution and active in vivo tracking to sites of known tumour following 8 of 16 i.v. infusions or 4 of 6 i.p. infusions. However, the leakage of 18F-FDG limited the ability to confidently confirm the tracking of MAK cells to tumour in all cases and improved PET labels are required. The addition of MDX-H210 bispecific antibody did not alter the distribution of cells to tumour sites, but did accelerate the clearance of i.v. administered MAK cells from the pulmonary circulation. This data demonstrates that cellular cancer immunotherapies may be successfully delivered to the sites of active tumour following either i.v. or i.p. injection in a proportion of patients with metastatic cancer. Incorporation of tracking studies in early cycles of cellular immunotherapy may allow selection of patients who demonstrate successful targeting of the immunotherapy for ongoing treatment.
datePublished:2006-05-30T00:00:00Z
dateModified:2006-05-30T00:00:00Z
pageStart:155
pageEnd:163
sameAs:https://doi.org/10.1007/s00262-006-0181-3
keywords:
Immunotherapy
Macrophage
Radiolabel
PET
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig4_HTML.jpg
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:56
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:D. Ritchie
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:L. Mileshkin
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:D. Wall
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:J. Bartholeyns
affiliation:
name:Immuno-Designed Molecules
address:
name:Immuno-Designed Molecules, Paris, France
type:PostalAddress
type:Organization
type:Person
name:M. Thompson
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:J. Coverdale
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:E. Lau
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:J. Wong
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:P. Eu
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:R. J. Hicks
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:H. M. Prince
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:56
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
name:Immuno-Designed Molecules
address:
name:Immuno-Designed Molecules, Paris, France
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:D. Ritchie
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
name:L. Mileshkin
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
name:D. Wall
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:J. Bartholeyns
affiliation:
name:Immuno-Designed Molecules
address:
name:Immuno-Designed Molecules, Paris, France
type:PostalAddress
type:Organization
name:M. Thompson
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:J. Coverdale
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:E. Lau
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:J. Wong
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:P. Eu
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:R. J. Hicks
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
name:H. M. Prince
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
name:University of Melbourne, Melbourne, Australia
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
name:University of Melbourne, Melbourne, Australia
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
name:Immuno-Designed Molecules, Paris, France
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
name:University of Melbourne, Melbourne, Australia
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
name:University of Melbourne, Melbourne, Australia
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(100)
- How much does https://www.springernature.com/gp/authors net monthly?
- Income figures for https://link.springernature.com/home/
- How much profit is https://order.springer.com/public/cart making per month?
- Income figures for https://submission.nature.com/new-submission/262/3
- What's the profit of https://www.springernature.com/gp/librarians/licensing/agc/journals?
- Income figures for https://doi.org/10.1200%2FJCO.2003.06.041
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12805342 generate?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Current%20developments%20in%20cancer%20vaccines%20and%20cellular%20immunotherapy&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2003.06.041&volume=21&pages=2415-2432&publication_year=2003&author=Ribas%2CA&author=Butterfield%2CLH&author=Glaspy%2CJA&author=Economou%2CJS
- Monthly income for https://doi.org/10.1161%2F01.CIR.0000149840.46523.FC
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15557385?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=In%20vivo%20tracking%20of%20stem%20cells%20for%20clinical%20trials%20in%20cardiovascular%20disease&journal=Circulation&doi=10.1161%2F01.CIR.0000149840.46523.FC&volume=110&pages=3378-3384&publication_year=2004&author=Frangioni%2CJ&author=Hajjar%2CR?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1295473
- How much does http://scholar.google.com/scholar_lookup?&title=Production%20of%20macrophages%20with%20potent%20antitumoral%20properties%20%28MAK%29%20by%20culture%20of%20monocytes%20in%20the%20presence%20of%20GM-CSF%20and%201%2C25%20%28OH%292%20vitD3&journal=Anticancer%20Res&volume=12&pages=2257-2260&publication_year=1992&author=Chokri%2CM&author=Lopez%2CM&author=Oleron%2CC&author=Girard%2CA&author=Martinache%2CC&author=Siffert%2CJC&author=Canepa%2CS&author=Bartholeyns%2CJ pull in monthly?
- What's the income generated by https://doi.org/10.1084%2Fjem.172.1.231 each month?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2193096
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Phagocytosis%20of%20tumor%20cells%20by%20human%20monocytes%20cultured%20in%20GM-CSF&journal=J%20Exp%20Med&doi=10.1084%2Fjem.172.1.231&volume=172&pages=231-237&publication_year=1990&author=Munn%2CD&author=Cheung%2CN?
- How much does https://doi.org/10.1016%2F0923-2494%2893%2980109-C earn?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Therapy%20of%20cancer%20metastases%20by%20systemic%20activation%20of%20macrophages&journal=Res%20Immunol&doi=10.1016%2F0923-2494%2893%2980109-C&volume=144&pages=284-287&publication_year=1992&author=Fidler%2CI&author=Kleinerman%2CE
- What is the earnings of https://doi.org/10.1016%2F0277-5379%2888%2990069-7?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3208813?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Control%20of%20the%20antitumoral%20activity%20of%20human%20macrophages%20produced%20in%20large%20amount%20in%20view%20of%20adoptive%20transfer&journal=Eur%20J%20Cancer%20Clin%20Oncol&doi=10.1016%2F0277-5379%2888%2990069-7&volume=24&pages=1691-1698&publication_year=1988&author=Dumont%2CS&author=Hartmann%2CD&author=Poindron%2CP&author=Faradji%2CA&author=Oberling%2CF&author=Bartholeyns%2CJ?
- Income figures for https://doi.org/10.1016%2Fj.imbio.2005.05.021
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Anti-tumor%20properties%20of%20human-activated%20macrophages%20produced%20in%20large%20scale%20for%20clinical%20application&journal=Immunobiol&doi=10.1016%2Fj.imbio.2005.05.021&volume=210&pages=267-277&publication_year=2005&author=Baron-Bodo%2CV&author=Doceur%2CP&author=Lefebvre%2CML&author=Labroqu%C3%A8re%2CK&author=Defaye%2CC&author=Cambouris%2CC&author=Prigent%2CD&author=Salcedo%2CM&author=Boyer%2CA&author=Nardin%2CA
- How much money does https://doi.org/10.1016%2F0022-1759%2894%2990033-7 make?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8083534's financial summary
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Large%20scale%20isolation%20of%20human%20blood%20monocytes%20by%20continuous%20flow%20centrifugation%20leukapheresis%20and%20counterflow%20centrifugation%20elutriation%20for%20adoptive%20cellular%20immunotherapy%20in%20cancer%20patients&journal=J%20Immunol%20Methods&doi=10.1016%2F0022-1759%2894%2990033-7&volume=174&pages=297-309&publication_year=1994&author=Faradji%2CA&author=Bohbot%2CA&author=Schmitt%2CM&author=Siffert%2CJ&author=Dumont%2CS&author=Wiesel%2CM&author=Piemont%2CY&author=Eischen%2CA&author=Bergerat%2CJ&author=Bartholeyns%2CJ&author=Poindron%2CP&author=Witz%2CJP&author=Oberling%2CF?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3180139?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Immunotherapy%20of%20cancer%3A%20experimental%20approach%20with%20activated%20macrophages%20proliferating%20in%20culture&journal=Cancer%20Detect%20Prev&volume=12&pages=413-420&publication_year=1988&author=Bartholeyns%2CJ&author=Lombard%2CY&author=Dumont%2CS&author=Hartmann%2CD&author=Chokri%2CM&author=Giaimis%2CJ&author=Kaufmann%2CS&author=Poindron%2CP
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2817800
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Compared%20antitumoral%20effects%20of%20LPS%2C%20TNF%2C%20interferon%20and%20activated%20macrophages%20on%20experimental%20tumors.%20Synergism%20and%20tissue%20distribution&journal=Anticancer%20Res&volume=9&pages=1185-1190&publication_year=1989&author=Chokri%2CM&author=Freudenberg%2CM&author=Galanos%2CC&author=Poindron%2CP&author=Bartholeyns%2CJ generate?
- How much revenue does https://doi.org/10.1097%2F00002371-199204000-00008 produce monthly?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Adoptive%20immunotherapy%20with%20activated%20macrophages%20grown%20in%20vitro%20from%20blood%20monocytes%20in%20cancer%20patients%3A%20a%20pilot%20study&journal=J%20Immunotherapy&doi=10.1097%2F00002371-199204000-00008&volume=11&pages=209-217&publication_year=1992&author=Lopez%2CM&author=Fechtenbaum%2CJ&author=David%2CB&author=Martinache%2CC&author=Chokri%2CM&author=Canepa%2CS&author=De%20Gramont%2CA&author=Louvet%2CC&author=Gorin%2CI&author=Mortel%2CO&author=Bartholeyns%2CJ each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2045866 generate monthly?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Phase%20I%20study%20of%20liposomal%20PTP-PE-activated%20autologous%20monocytes%20administered%20intraperitoneally%20to%20patients%20with%20peritoneal%20carcinomatosis&journal=J%20Clin%20Oncol&volume=9&pages=1251-1260&publication_year=1991&author=Faradji%2CA&author=Bohbo%2CA&author=Frost%2CH&author=Schmitt-Goguel%2CM&author=Siffert%2CJC&author=Dufour%2CP&author=Eber%2CM&author=Lallot%2CC&author=Wiesel%2CML&author=Bergerat%2CJP&author=Oberling%2CF?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7545221 make?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Phase%20I%20trial%20of%20bispecific%20antibody%20MDX-H210%20in%20patients%20with%20advanced%20breast%20or%20ovarian%20cancer%20that%20overexpresses%20the%20proto-oncogene%20HER-a%20neu&journal=J%20Clin%20Oncol&volume=13&pages=2281-2292&publication_year=1995&author=Valone%2CF&author=Kaufman%2CP&author=Guyre%2CP?
- How much revenue does https://doi.org/10.1016%2Fj.ygyno.2003.12.010 produce monthly?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14984957's gross income?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Rates%20of%20topoisomerase%20II-alpha%20and%20HER-2%20gene%20amplification%20and%20expression%20in%20epithelial%20ovarian%20carcinoma&journal=Gynecol%20Oncol&doi=10.1016%2Fj.ygyno.2003.12.010&volume=92&issue=3&pages=887-895&publication_year=2004&author=Mano%2CMS&author=Awada%2CA&author=Di%20Leo%2CA&author=Durbecq%2CV&author=Paesmans%2CM&author=Cardoso%2CF&author=Larsimont%2CD&author=Piccart%2CM?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9435876 earns monthly
- How much money does http://scholar.google.com/scholar_lookup?&title=Clinical%20experience%20with%20CD64-directed%20immunotherapy.%20An%20overview&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs002620050435&volume=45&pages=210-215&publication_year=1997&author=Curnow%2CRT make?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12079309 makes per month
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Adoptive%20immunotherapy%20of%20ovarian%20carcinoma&journal=Gynecol%20Oncol&volume=86&pages=102-103&publication_year=2002&author=Gramont%2CA&author=Gangji%2CD&author=Louvet%2CC&author=Garcia%2CML&author=Tardy%2CD&author=Romet-Lemonne%2CJL
- How much does http://scholar.google.com/scholar_lookup?&title=Biodistribution%20of%20indium-labelled%20macrophages%20in%20mice%20bearing%20solid%20tumors&journal=Int%20J%20Immunother&volume=6&pages=79-84&publication_year=1990&author=Chokri%2CM&author=Lallot%2CC&author=Ebert%2CM&author=Poindron%2CP&author=Bartholeyns%2CJ gross monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10994674 generate?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=18F-FDG%20labelling%20of%20human%20leucocytes&journal=Nucl%20Med%20Commun&volume=21&pages=691-694&publication_year=2000&author=Forstrom%2CLA&author=Mullan%2CBP&author=Hung%2CJC&author=Lowe%2CVJ&author=Thorson%2CLM?
- https://doi.org/10.1161%2F01.CIR.0000163546.27639.AA's revenue stream
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15851598?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Monitoring%20of%20bone%20marrow%20cell%20homing%20into%20the%20infarcted%20human%20myocardium&journal=Circulation&doi=10.1161%2F01.CIR.0000163546.27639.AA&volume=111&issue=17&pages=2198-2202&publication_year=2005&author=Hofmann%2CM&author=Wollert%2CKC&author=Meyer%2CGP&author=Menke%2CA&author=Arseniev%2CL&author=Hertenstein%2CB&author=Ganser%2CA&author=Knapp%2CWH&author=Drexler%2CH?
- How much does https://doi.org/10.1080%2F14653240310002207 net monthly?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12944233
- How much money does http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20cellular%20therapies%3A%20the%20Australian%20perspective&journal=Cytotherapy&doi=10.1080%2F14653240310002207&volume=5&issue=4&pages=284-288&publication_year=2003&author=Wall%2CDM&author=Prince%2CHM generate?
- How much does https://doi.org/10.1073%2Fpnas.052709599 pull in?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11867752 make?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Ex%20vivo%20cell%20labeling%20with%2064Cu-pyruvaldehyde-bis%28N4-methylthiosemicarbazone%29%20for%20imaging%20cell%20trafficking%20in%20mice%20with%20positron-emission%20tomography&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.052709599&volume=99&pages=3030-3035&publication_year=2002&author=Adonai%2CN&author=Nguyen%2CKN&author=Walsh%2CJ&author=Iyer%2CM&author=Toyokuni%2CT&author=Phelps%2CME&author=McCarthy%2CT&author=McCarthy%2CDW&author=Gambhir%2CSS generate?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11761442 each month?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Biodistribution%20of%20111indium-labeled%20macrophages%20infused%20intravenously%20in%20patients%20with%20renal%20carcinoma&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs002620100224&volume=50&issue=9&pages=477-482&publication_year=2001&author=Quillien%2CV&author=Moisan%2CA&author=Lesimple%2CT&author=Leberre%2CC&author=Toujas%2CL?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12690521 have?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Injection%20by%20various%20routes%20of%20melanoma%20antigen-associated%20macrophages%3A%20biodistribution%20and%20clinical%20effects&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-003-0390-y&volume=52&issue=7&pages=438-444&publication_year=2003&author=Lesimple%2CT&author=Moisan%2CA&author=Carsin%2CA&author=Ollivier%2CI&author=Mousseau%2CM&author=Meunier%2CB&author=Leberre%2CC&author=Collet%2CB&author=Quillien%2CV&author=Drenou%2CB&author=Lefeuvre-Plesse%2CC&author=Chevrant-Breton%2CJ&author=Toujas%2CL is on a monthly basis
- How much does https://citation-needed.springer.com/v2/references/10.1007/s00262-006-0181-3?format=refman&flavour=references generate monthly?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D.%20Ritchie produce monthly?
- Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D.%20Ritchie%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=L.%20Mileshkin?
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22L.%20Mileshkin%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D.%20Wall bring in?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D.%20Wall%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20Bartholeyns each month?
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20Bartholeyns%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Thompson generate monthly?
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Thompson%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20Coverdale?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20Coverdale%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=E.%20Lau earn?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22E.%20Lau%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20Wong makes per month
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20Wong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=P.%20Eu?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22P.%20Eu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R.%20J.%20Hicks earns monthly
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R.%20J.%20Hicks%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=H.%20M.%20Prince?
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22H.%20M.%20Prince%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How profitable is https://s100.copyright.com/AppDispatchServlet?title=In%20vivo%20tracking%20of%20macrophage%20activated%20killer%20cells%20to%20sites%20of%20metastatic%20ovarian%20carcinoma&author=D.%20Ritchie%20et%20al&contentID=10.1007%2Fs00262-006-0181-3©right=Springer-Verlag&publication=0340-7004&publicationDate=2006-05-30&publisherName=SpringerNature&orderBeanReset=true?
- How much does https://citation-needed.springer.com/v2/references/10.1007/s00262-006-0181-3?format=refman&flavour=citation gross monthly?
- What's the financial outcome of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- Earnings of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- What's the financial gain of https://www.springernature.com/gp/products?
- See how much https://www.springernature.com/gp/librarians makes per month
- What's the income of https://www.springernature.com/gp/societies?
- Income figures for https://www.springernature.com/gp/partners
- How much does https://www.springer.com/ generate monthly?
- How much does https://www.nature.com/ pull in monthly?
- See how much https://www.biomedcentral.com/ makes per month
- What's the revenue for https://www.palgrave.com/?
- What's the financial intake of https://www.apress.com/?
- What is the monthly revenue of https://www.springernature.com/gp/legal/ccpa?
- What are the total earnings of https://www.springernature.com/gp/info/accessibility?
- https://support.springernature.com/en/support/home's revenue stream
- How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations pull in monthly?
- What's the financial intake of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref